C

Concert Pharmaceuticals

63 employees

Concert Pharmaceuticals is a biotechnology company that uses deuterium chemistry to develop drug products that address patient needs.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

2006

Funding rounds raised

Total raised

$66M

from 23 investors over 23 rounds

C

Concert Pharmaceuticals raised $66M on June 1, 2022

Investors: RA Capital Management, L.P.

C

Concert Pharmaceuticals raised $30M on June 12, 2017

Investors: Hercules Capital, Inc.

C

Concert Pharmaceuticals raised $37M on April 30, 2008

Investors: TVM Life Science Management Inc, Mediphase Venture Partners, Three Arch Partners, New Leaf Venture Partners, Sky Ventures, QVT Financial LLP, Greylock Partners and Flagship Ventures

C

Concert Pharmaceuticals raised $49M on November 30, 2006

Investors: Three Arch Partners, TVM Life Science Management Inc, QVT Financial LLP, New Leaf Venture Partners, Flagship Ventures, Greylock Partners, Sky Ventures and Brookside Capital Inc

C

Concert Pharmaceuticals raised $10M on July 17, 2006

Investors: TVM Life Science Management Inc, Three Arch Partners, Sky Ventures, QVT Financial LLP and Greylock Partners

FAQ